Skip to main content
OpenTrials

Clinical trial condition

Meningeal Carcinomatosis

Explore clinical trials studying Meningeal Carcinomatosis. Study availability and eligibility vary by location and protocol.

99 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Meningeal Carcinomatosis trial results

Active, Not Recruiting

Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors

NCT06462222

Conditions
Central Nervous System Neoplasms, Leptomeningeal Metastasis, Meningeal Carcinomatosis, +5 more
Locations
  • The Affiliated Huizhou Hospital, Guangzhou Medical University Huizhou, Guangdong, China
  • Huizhou First Hospital Affiliated to Guangdong Medical University Huizhou, Guangdong, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
  • Cancer Center, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine Beijing, China
View Trial Details
Active, Not Recruiting

GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases

NCT04192981

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +9 more
Locations
  • BAPTIST ALLIANCE - MCI (Data Collection Only) Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent only) Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Intrathecal Double Checkpoint Inhibition

NCT05598853

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • University Hospital Zurich Zurich, Canton of Zurich, Switzerland
  • University Hospital Basel Basel, Switzerland
  • University Hospital Geneva Geneva, Switzerland
View Trial Details
Active, Not Recruiting

Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

NCT05034497

Conditions
Central Nervous System Neoplasms, Leptomeningeal Metastasis, Meningeal Carcinomatosis, +5 more
Locations
  • Northwestern Memorial Hospital Olson Pavilion Chicago, Illinois, United States
  • Northshore University Hospital Manhasset, New York, United States
  • Lenox Hill Hospital New York, United States
  • Ohio State University Hospital Columbus, Ohio, United States
View Trial Details

Related conditions